Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic disease characterized by fibroblast expansion, and tissue remodeling. It is considered a multifactorial disease but the possible involved genes are largely unknown. Interestingly, studies regarding the possible role of major histocompatibility complex (MHC) are scanty and show contradictory results. In this study, we evaluated the polymorphisms of the MHC, locus HLA-B, -DRB1, and -DQB1 in a cohort of 75 IPF patients and 95 controls by using PCR and hybridization with sequence-specific oligonucleotide probes. In addition, we examined the effect of bronchoalveolar lavage (BAL) from IPF patients with different MHC haplotypes on alveolar epithelial growth rate by WST-1 cell viability assay and on epithelial apoptosis by flow cytometry and by cleaved caspase-3 in cell homogenates. Three haplotypes were significantly increased in IPF: (1) HLA-B*15-DRB1*0101-DQB1*0501 (OR=10.72, CI=1.43–459.6; pC=0.011); (2) HLA-B*52-DRB1*1402-DQB1*0301 (OR=4.42, CI=1.21–24.1; pC=0.024); and (3) HLA-B*35-DRB1*0407-DQB1*0302 (OR=4.73, CI=1.53–19.5; pC=0.005). BAL from patients with the later haplotype significantly reduced epithelial growth rate (∼30%) and caused epithelial cell apoptosis assayed by cleaved caspase-3 (351.7±16.5 pg/106 cells versus 264±24 from controls, and 274±36.8 and 256.5±10.7 from the other haplotypes; P<0.05), and DNA breaks labeling by flow cytometry (23.7±6.9% versus 3.1±0.7% from controls, and 6.5±0.6% and 7.6±1.2% from the other two haplotypes; P<0.01). These findings suggest that some MHC polymorphisms confer susceptibility to IPF, which might be related with the induction of epithelial cell apoptosis, a critical process in the development of the disease.
Similar content being viewed by others
References
Alaez C, Vazquez-Garcia MN, Gorodezky C (2001) DQA1 and DQB1 promoter diversity and linkage disequilibrium with class II haplotypes in Mexican Mestizo population. Genes Immun 2:216–221
Alaez C, Infante E, Pujol J, Duran C, Navarro JL, Gorodezky C (2002) Molecular analysis of HLA-DRB1, DQA1, DQB1, DQ promoter polymorphism and extended class I/class II haplotypes in the Seri Indians from Northwest Mexico. Tissue Antigens 59:388–396
American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646–664
American Thoracic Society/European Respiratory Society (2002) International multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304
Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM (1999) Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol 20:106–112
Barbas-Filho JV, Ferreira MA, Sesso A, Kairalla RA, Carvalho CR, Capelozzi VL (2001) Evidence of type II pneumocyte apoptosis in the pathogenesis of IPF/usual interstitial pneumonia (UIP). J Clin Pathol 54:132–138
Beck S, Trowsdale J (2000) The human major histocompatability complex: lessons from the DNA sequence. Annu Rev Genomics Hum Genet 1:117–137
Blancheteau V, Charron D, Mooney N (2002) HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases. Hum Immunol 63:375–383
Drenou B, Blancheteau V, Burgess DH, Fauchet R, Charron DJ, Mooney NA (1999). A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J. Immunol 163:4115–4124
Du Bois RM (2002) The genetic predisposition to interstitial lung disease: functional relevance. Chest 121:14S–20S
Fulmer JD, Sposovska MS, von Gal ER, Crystal RG, Mittal KK (1978) Distribution of HLA antigens in idiopathic pulmonary fibrosis. Am Rev Respir Dis 118:141–147
Gerbase-DeLima M, Pereira-Santos A, Sesso R, Temin J, Aragao ES, Ajzen H (1998) Idiopathic focal segmental glomerulosclerosis and HLA antigens. Braz J Med Biol Res 31:387–389
Glicklich D, Haskell L, Weiss RA (1988) Possible genetic predisposition to idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 12:26–30
Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L, Umans L, Schrijvers V, Checler F, Vanderstichele H, Baekelandt V, Dressel R, Cupers P, Huylebroeck D, Zwijsen A, Van Leuven F, De Strooper B (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A 96:11872–11877
Hodgson U, Tukiainen P, Laitinen T (2005) The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respir Med 99:265–267
Holling TM, Schooten E, van Den Elsen PJ (2004) Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum Immunol 65:282–290
Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, Welsh KI, Du Bois RM, Petrek M (2002) Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165:148–151
Kallenberg CG, Schilizzi BM, Beaumont F, De Leij L, Poppema S, The TH (1987). Expression of class II MHC antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. J Clin Pathol 40:725–733
Katzenstein ALA, Myers JL (1998) Idiopathic pulmonary fibrosis. Clinical relevance of pathological classification. Am J Respir Crit Care Med 157:1301–1315
Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, Du Bois RM (2003) Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis. Respir Res 4(1):6
Libby DM, Gibofsky A, Fotino M, Waters SJ, Smith JP (1983) Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2. Am Rev Respir Dis 127:618–622
Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N (2001) Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur Respir J 17:180–189
McCluskey J, Peh CA (1999) The human leukocyte antigens and clinical medicine: an overview. Rev Immunogenet 1:3–20
Nakayama A, Nagura H, Yokoi T, Ito M, Asai J (1992) Immunocytochemical observation of paraquat-induced alveolitis with special reference to class II MHC antigens. Virchows Arch B Cell Pathol Incl Mol Pathol 61:389–396
Olerup O, Aldener A, Fogdell A (1993) HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41:119–134
Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM (2001) Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 163:1432–1436
Pardo A, Selman M (2002) Molecular mechanisms of pulmonary fibrosis. Front Bioscience 7, d1743–1761, August 1
Pardo A, Barrios R, Gaxiola M, Segura L, Carrillo G, Estrada A, Mejía M, Selman M (2000) Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med 161:1698–1704
Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1997) GeneCards: encyclopedia for genes, proteins and diseases. Weizmann Institute of Science, Bioinformatics Unit and Genome Center (Rehovot, Israel), World Wide Web URL: http://bioinformatics.weizmann.ac.il/cards, last updated: January 11, 2005
Rhodes DA, Trowsdale J (1999) Genetics and molecular genetics of the MHC. Rev Immunogenet 1:21–31
Robinson J, Malik A, Parham P, Bodmer JG, Marsh SG (2000) IMGT/HLA database[em]a sequence database for the human major histocompatibility complex. Tissue Antigens 55:280–287
Selman M, King TE, Pardo A (2001) Idiopathic pulmonary fibrosis: prevaling and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134:136–151
Selman M, Lin HM, Montaño M, Jenkins AL, Estrada A, Lin Z, Wang G, DiAngelo SL, Guo X, Pardo A, Phelps DS, Floros J (2003) Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113:542–550
Selman M, Estrada A, Mejía M, Gaxiola M, Suárez T, Alonso D, Navarro C, Pardo A, Carrillo G (2005) Accelerated idiopathic pulmonary fibrosis represents a distinct subtype of IPF. Proc Am Thorac Soc 2:A243
Thannickal VJ, Toews GB, White ES, Lynch JP III, Martinez FJ (2004) Mechanisms of pulmonary fibrosis. Annu Rev Med 55:395–417
Turton CW, Morris LM, Lawler SD, Turner-Warwick M (1978) HLA in cryptogenic fibrosing alveolitis. Lancet 1:507–508
Uhal BD, Joshi I, Hughes WF, Ramos C, Pardo A, Selman M (1998) Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 275:L1192–L1199
Vargas-Alarcon G, Hernandez-Pacheco G, Zuniga J, Rodriguez-Perez JM, Perez-Hernandez N, Rangel C, Villarreal-Garza C, Martinez-Laso J, Granados J, Arnaiz-Villena A (2003) Distribution of HLA-B alleles in Mexican Amerindian populations. Immunogenetics 54:756–760
Varpela E, Tiilikainen A, Varpela M, Tukiainen P (1979) High prevalences of HLA-B15 and HLA-Dw6 in patients with cryptogenic fibrosing alveolitis. Tissue Antigens 14:68–71
Vazquez de Lara L, Becerril C, Montano M, Ramos C, Maldonado V, Melendez J, Phelps DS, Pardo A, Selman M (2000) Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am J Physiol 279:L950–L957
Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A, Fabbri M, Hall I, Britton J, Johnston I, Di Giovine F (2000) Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 162:755–758
Wu YH, Shih SF, Lin JY (2004) Ricin triggers apoptotic morphological changes through caspase-3 cleavage of BAT3. J Biol Chem 279:19264–19275
Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C (2003) Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168:431–435
Zanelli E, Breedveld FC, de Vries RRP (2000) HLA association with autoimmune disease: a failure to protect? Rheumatology 39:1060–1066
Zetterquist H, Bengtsson M, Backstrom G, Egle-Jansson I, Ekdahl AM, Grunnet N, Gustafsson I, Knutsen I, Kuhle A, Rydberg L, Spurkland A, Steffensen R, Storgards M, Szojmer E, Soderholm G, Thuresson B, Turesson H, Olerup O (1997) Report from the HLA class II typing by PCR-SSP Multicentre Study. Eur J Immunogenet 24:191–199
Zorzetto M, Ferrarotti I, Trisolini R, Agli LL, Scabini R, Novo M, De Silvestri A, Patelli M, Martinetti M, Cuccia M, Poletti V, Pozzi E, Luisetti M (2003) Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168:330–334
Acknowledgments
This study was supported by a Grant from CONACYT# 43832-M. This work was submitted in partial fulfillment of the requirements to obtain the PhD degree for R.F.V. at Biomedical Sciences, UNAM.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Falfán-Valencia, R., Camarena, A., Juárez, A. et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum Genet 118, 235–244 (2005). https://doi.org/10.1007/s00439-005-0035-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-005-0035-7